Stock listing
INTS Stock Price, News, Filings & Events — Intensity Therapeutics, Inc.
Selected listing: INTS · NASDAQ · USD · US
This page tracks Intensity Therapeutics, Inc.'s INTS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INTS:NASDAQ. INTS:NASDAQ is the stock-level entry point for investors researching Intensity Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Intensity Therapeutics, Inc. is a public company traded under the ticker INTS in the American market. The company has a market capitalization of approximately $12 million. Intensity Therapeutics focuses on innovative therapeutic solutions in the healthcare sector.
- Ticker
- INTS:NASDAQ
- Asset type
- Stock
- Market cap
- $13.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Intensity Therapeutics, Inc. INTS:NASDAQ stock context
This page tracks Intensity Therapeutics, Inc.'s INTS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INTS:NASDAQ. INTS:NASDAQ is the stock-level entry point for investors researching Intensity Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Intensity Therapeutics, Inc. is a public company traded under the ticker INTS in the American market. The company has a market capitalization of approximately $12 million. Intensity Therapeutics focuses on innovative therapeutic solutions in the healthcare sector.
Latest news from Intensity Therapeutics, Inc.
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Intensity Therapeutics : to Announce Second Quarter 2026 Financial Results on August 11, 2026
August 4, 2026
Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Tri...
July 15, 2026
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
Intensity Therapeutics, Inc. earnings calls
Research Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for INTS:NASDAQ.
Intensity Therapeutics, Inc. company profile
View the public company page for Intensity Therapeutics, Inc. on 6ix.
Intensity Therapeutics, Inc. news
Read company news and market updates connected to Intensity Therapeutics, Inc..
Intensity Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Intensity Therapeutics, Inc..